[Effect of peripheral opiate receptor agonist dalargin on exercise tolerance in patients with coronary and peripheral arteries atherosclerosis].
Maslov
L N
LN
Fedorova
N A
NA
Dudko
V A
VA
Karpov
R S
RS
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy / Q000503:physiopathology*; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005080:Exercise Test; D017079:Exercise Tolerance / Q000187:drug effects* / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology*; D011957:Receptors, Opioid / Q000819:agonists*
D011957:Receptors, Opioid; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-